Unravelling the Proteomics of HLA-B*57:01+ Antigen Presenting Cells during Abacavir Medication

Autor: Funmilola Haukamp, Eline Gall, Gia-Gia Hò, Wiebke Hiemisch, Florian Stieglitz, Joachim Kuhn, Rainer Blasczyk, Andreas Pich, Christina Bade-Döding

Publikováno v: Journal of Personalized Medicine, Vol 12, Iss 40, p 40 (2022)
Journal of Personalized Medicine
Journal of Personalized Medicine; Volume 12; Issue 1; Pages: 40

Type B adverse drug reactions (ADRs) are unpredictable based on the drug’s pharmacology and represent a key challenge in pharmacovigilance. For human leukocyte antigen (HLA)-mediated type B ADRs, it is assumed that the protein/small-molecule intera

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8b50aa7667770111661945dbf767c63f
https://www.mdpi.com/2075-4426/12/1/40